Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

NCT02633800 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

87

Enrollment

INDUSTRY

Sponsor class

Stopped Trial was terminated by sponsor due to lack of efficacy.

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Patritumab
DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Placebo

Sponsor

Daiichi Sankyo